Sales decline 10.55% to Rs 200.25 crore
Net profit of Astrazeneca Pharma India declined 21.16% to Rs 21.05 crore in the quarter ended December 2020 as against Rs 26.70 crore during the previous quarter ended December 2019. Sales declined 10.55% to Rs 200.25 crore in the quarter ended December 2020 as against Rs 223.86 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales200.25223.86 -11 OPM %15.3516.42 -PBDT33.4139.95 -16 PBT28.3035.18 -20 NP21.0526.70 -21Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content